The abortion pill mifepristone, used in the majority of U.S. abortions, faces an uncertain future under the new Republican administration.
President Donald Trump’s pick for Food and Drug Administration (FDA) commissioner, Dr Marty Makary, was confirmed on Tuesday by the Senate.